Search the TFS Resource Library
Search by keyword, or choose a Therapeutic Area to view all resources within that area of study.
Search by keyword, or choose a Therapeutic Area to view all resources within that area of study.
When a tight oncology RWE deadline moved forward by 10 days, TFS HealthScience restructured the team and delivered. Download the case study to find out how.
DownloadTFS HealthScience is implementing AI to deliver feasibility assessments faster. See how AI and human judgement work together to answer every trial’s first question.
DownloadHow the TFS Medical Writing team delivered a clinic-ready protocol in two months, from a single slide deck.
DownloadA plain-English breakdown of FSP vs full-service CRO for DACH biotech, covering local regulatory context and what to look for in a partner.
DownloadCombination therapy trials require clear, compliant protocols to manage complexity and risk. Download our white paper for expert medical writing insights on effective protocol development.
DownloadGain practical strategies for managing placebo risk and ensuring credible, compliant dermatology trial results.
Watch NowLGBTQ+ patients want to take part in clinical research. Most are never asked. Here is what the science says and what better recruitment looks like in practice.
Read NowBiomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
Read NowLearn how ARVO 2026 signals a new era of precision ophthalmology, where smarter recruitment, imaging consistency and patient‑centric design demand deep‑tier partnerships like those offered by TFS.
Read NowThe FDA reminded over 2,200 sponsors to submit overdue ClinicalTrials.gov results. This how TFS Medical Writing team can help.
Read NowExperienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Read NowPsoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.
Read NowExplore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Read NowExplore how sponsors can stay ahead of evolving regulatory demands, tech shifts, and enrollment pressures in today’s complex clinical trial landscape.
Read NowDiscover how natural history data, external controls, and RWE are reshaping rare neurological disease trials for smarter, regulatory-ready design.
Read Now